Supplement
Plant sterols and stanols
Plant sterols and stanols lower LDL ('bad') cholesterol modestly. In trials of adults, mostly using spreads and dairy foods with added sterols, LDL fell by about 6% to 12%, the fall growing with intake up to about 3 g a day, and sterols and stanols worked alike; a 2026 umbrella review rated the certainty of this LDL evidence as generally high. Capsule and tablet results are mixed: an older pooled analysis matched the foods, but a 2023 trial found a sterol supplement no better than placebo after 28 days. No trial has tested whether they prevent heart attacks or deaths. They lower blood beta-carotene and other carotenoids, and people with sitosterolaemia, a rare inherited disorder, should avoid them.
Sources: PMID 24780090; PMID 42275989; PMID 24144075; PMID 36351465; PMID 24468148; PMID 27591863; PMID 25941971
- Updated
- How we grade
- 19 studies cited
- Best evidence
- Grade A: strong evidence
What the evidence says
- LDL cholesterol in enriched foods: the main evidence, with sterols and stanols alike. A 2014 meta-analysis of 124 randomised studies in adults (201 study arms: 129 testing plant sterols, 59 testing stanols, the rest a mix), most of them giving the sterols in margarines, spreads or dairy-type products, found LDL fell step by step against placebo products as intake rose: by 5.7% in the 24 arms averaging 0.6 g a day and by 12.4% in the 27 arms averaging 3.3 g a day, where sterols lowered LDL by 12.3% and stanols by 12.5%; the authors call the two dose responses clear and comparable, and studies above 4 g a day were too few to pool. Two of its three authors work for Unilever, which markets sterol-enriched foods. A 2026 umbrella review drew on 14 meta-analyses in all (9 on blood fats) of adults taking supplements or enriched fats, oils, dairy foods, grains or drinks, and its summary gives no trial number for any single result: the LDL reductions in those analyses ranged between 0.26 and 0.36 mmol/L, falls of 0.2 mmol/L or more appeared from 0.5 to 1 g a day, and certainty for LDL was generally high, while HDL, fasting glucose, HbA1c and body weight did not change. EU conditions of use set a maximum of 3 g a day of added plant sterols per person.
- Capsules and tablets: mixed results. A 2013 meta-analysis of 8 trials in all of sterol or stanol capsules and tablets, whose summary gives no separate trial count for its LDL result, found LDL 0.31 mmol/L (12 mg/dL) lower than with placebo after 4 to 6 weeks, taken mostly with main meals, and the same size of fall as with enriched foods; its reference list includes stanol tablets, softgel capsules and a double-blind crossover trial of 41 men and women with mild to moderate high cholesterol, in which LDL and total cholesterol after 4 weeks of 2 g a day of sterol softgels were not significantly different from sunflower-oil placebo capsules. In a 2023 single-blind trial completed by 190 adults at raised heart risk, a plant sterol supplement taken for 28 days did not lower LDL significantly more than placebo, while a low dose of the statin rosuvastatin lowered it 35.2% more than placebo. A 2023 systematic review of 10 trials of capsules or tablets in adults with high cholesterol, which did not pool them, found that most reported a cholesterol fall despite short treatment and called for more research on these formats.
- Added to a statin. A 2016 meta-analysis of 15 randomised trials in all (500 people already on statins) found LDL 0.30 mmol/L lower when sterols or stanols were added than with the statin alone, from the 14 trials that reported LDL (8 of them significant on their own); HDL and triglycerides did not change. Ten of its 14 studies gave the sterols or stanols in margarine, and one each used fermented milk, beta-sitosterol, a stanol tablet and capsules. Several of its authors listed Nestle research centres as their workplace. A European Atherosclerosis Society consensus panel judged the extra LDL fall on a statin to be about what doubling the statin dose gives.
- Heart attacks and deaths: not tested. The same expert panel states that there are no randomised trials with hard end points, such as heart attacks or deaths, to establish clinical benefit, so the case for sterols rests on the LDL fall. Studies of natural blood levels, not of people taking sterol products, point in different directions: a 2012 meta-analysis of 17 observational studies (11,182 participants; 8 giving risk ratios and 15 comparing people with and without heart disease), whose first author received an educational grant from Danone Research, found no link between blood sitosterol or campesterol and cardiovascular disease, with signs of publication bias, while a 2022 genetic study of up to 9,758 people, using Mendelian randomization, found that genetically higher blood sitosterol raised the risk of coronary artery disease, partly through cholesterol.
- Inherited high cholesterol, including in children. In familial hypercholesterolaemia, a 2014 Cochrane review pooled 4 short trials (129 children and adults), three of them with sterol-enriched spreads, and found LDL 0.60 mmol/L lower when plant sterols were added to a cholesterol-lowering diet than with the diet alone; none of its 15 trials in all measured heart disease, deaths or age at death. A 2020 systematic review of 12 studies in children and adolescents with high cholesterol reported LDL falls of about 10% and no adverse effects, though some of its trials found lower blood beta-carotene, alpha-carotene, lycopene, alpha-tocopherol or retinol; and in a double-blind crossover trial in 31 children and adolescents, sterol capsules taken with a cholesterol-lowering diet for 8 weeks changed LDL no more than placebo capsules of sunflower oil. A child's treatment should be set by their doctor.
- Beta-sitosterol and the prostate. Beta-sitosterol, the main sterol in many plant-sterol extracts, is sold mostly for urinary symptoms of an enlarged prostate and has its own page. In brief, in two 6-month double-blind trials in Germany of 200 and 177 men, symptom scores improved and urine flow rose more than on placebo, and in the 200-man trial the prostate did not shrink in either group.
Safety and when to see a clinician
- Lower carotenoids and vitamin E in the blood. A 2017 meta-analysis of 41 randomised trials (3,306 people) of plant sterols or stanols, mostly in enriched foods, found beta-carotene 16.3% lower than with placebo (10.1% once the cholesterol fall was taken into account; 53 comparisons), alpha-carotene 14.4% lower (38) and lycopene 12.3% lower (42), with smaller falls in lutein, zeaxanthin, beta-cryptoxanthin and the vitamin E forms alpha- and gamma-tocopherol; vitamin A (retinol) and vitamin D did not change, and levels stayed within normal ranges. Whether these falls matter clinically is unknown, the authors write, and cite reports that eating at least five servings of vegetables or fruit a day can prevent the carotenoid fall. Two of them work for Unilever, which funded the review through a restricted grant.
- Sitosterolaemia: avoid sterol products. In this rare inherited disorder (also called phytosterolaemia), faults in the ABCG5 or ABCG8 genes stop the body clearing plant sterols and stanols, which build up in the blood and tissues; it brings early artery disease, fatty lumps in the skin and tendons (xanthomas), and blood problems such as haemolysis and low platelets, and cutting dietary plant sterols is one of the main recommendations. In everyone else, sterol-enriched foods raise blood plant sterols too: a 2013 meta-analysis of 41 studies in all, whose summary gives no separate count for each sterol, found blood sitosterol 31% and campesterol 37% higher than on control foods, while total plant sterols stayed below 1% of the sterols in blood; the European Atherosclerosis Society panel notes that marked rises may promote artery disease, but that the higher levels seen with the intakes it reviewed have not been linked to harm in long-term human studies.
- Cholesterol medicines, cooking and labels. Sterols add to a statin's LDL fall, so do not drop a prescribed cholesterol drug, and let your clinician know before you add them. A 2020 opinion of the European Food Safety Authority records that the first EU approval of sterol spreads required labels telling people on cholesterol-lowering medicine to use them only under medical supervision, and that earlier EU scientists judged it prudent to avoid more than 3 g a day of plant sterols, because more brought no extra cholesterol fall and the health effect of a lasting drop in beta-carotene is largely unknown. The same opinion could not establish that using sterol-ester spreads for cooking and baking is safe, because heating forms plant sterol oxidation products.
- Pregnancy, breastfeeding and young children. As the 2020 EFSA opinion sets out, EU labels on foods with added plant sterols must state that the food is meant only for people who want to lower their blood cholesterol and may not be nutritionally appropriate for pregnant or breastfeeding women or for children under 5; EU scientists reasoned that the beta-carotene fall could matter where vitamin A status is not optimal, as may be the case in pregnancy, breastfeeding and early childhood. EFSA also calculated that if sterol-ester spreads were used for cooking, high consumers of every age could take in more oxidation products than the level it considers safe, and children under 9 could do so even at typical oxidation rates. If you are pregnant or breastfeeding, raise sterol products with your midwife or doctor before starting, and let a doctor decide whether a child should have them.
- When to see a clinician. Have urinary symptoms such as a weak stream or getting up at night checked before treating them yourself, and see a doctor about cholesterol that is very high, runs in your family or comes with yellowish deposits on tendons or eyelids.
Safety note. Talk to a doctor or pharmacist before you start plant sterols and stanols if you take prescription medicines, are pregnant or breastfeeding, or have a long-term health condition. Supplements can interact with medicines.
What plant sterols and stanols is good for
How we grade →Strong evidence
Low-density lipoprotein (LDL): Improves
All 1 outcome ↓
Shop the evidence-backed picks
We may earn a commission from these links, at no cost to you. Disclosures
Where to buy · affiliate links
- iHerbBluebonnet Nutrition Plant Sterols, 90 Vegetable CapsulesBuy on iHerb
Grade A
No official safety summary is available for this supplement. If you take prescription medicines, are pregnant or breastfeeding, or have a long-term condition, check with a pharmacist before starting.
Prices and stock are on the retailer's page.
Compare more products
Plant sterols and stanols products we can link to, in the forms the graded studies used where we can match them.
- Grade A
Links to Thorne, Fullscript or iHerb carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
AHigh Cholesterol
▲ Low-density lipoprotein (LDL)1 outcome · 2 studies
High Cholesterol: all the evidence on its own page
| Grade | Outcome | Effect | Size and studies |
|---|---|---|---|
| A | Low-density lipoprotein (LDL)Small DecreaseStudied as: Plant sterols or stanols taken by mouth with meals, about 1 to 3 g a day for 4 weeks or longer, in adults with normal or raised cholesterol: as capsules or tablets compared with placebo (8 trials), or added to foods such as spreads and yogurt drinks compared with the same foods without them (124 trials). Both forms lowered LDL cholesterol by a similar amount.Studies that measured low-density lipoprotein (ldl) (2 studies)
| Improves | Small effect · 2 studiesReviewed |
Studies cited
19 studies from PubMed
- LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies.
- Efficacy of phytosterols for reduction of cardiometabolic risk factors: An umbrella review of systematic reviews and meta-analyses and updated dose-response meta-analyses of randomized trials.
- Safety of the extension of use of plant sterol esters as a novel food pursuant to Regulation (EU) 2015/2283.
- Cholesterol-lowering efficacy of plant sterols/stanols provided in capsule and tablet formats: results of a systematic review and meta-analysis.
- Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial.
- Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers.
- Phytosterol supplementation in capsules or tablets as adjunctive treatment for hypercholesterolemia: A systematic review of randomized controlled trials.
- Effects of plant stanol or sterol-enriched diets on lipid profiles in patients treated with statins: systematic review and meta-analysis.
- Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.
- Plant sterols and cardiovascular disease: a systematic review and meta-analysis.
Show all 19 studies
- Genome-wide meta-analysis of phytosterols reveals five novel loci and a detrimental effect on coronary atherosclerosis.
- Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.
- Phytosterol supplementation in the treatment of dyslipidemia in children and adolescents: a systematic review.
- Effect of phytosterol capsule supplementation associated with the National Cholesterol Education Program Step 2 diet on low-density lipoprotein in children and adolescents with dyslipidemia: A double-blind crossover trial.
- Plasma fat-soluble vitamin and carotenoid concentrations after plant sterol and plant stanol consumption: a meta-analysis of randomized controlled trials.
- Plant Sterols, Stanols, and Sitosterolemia.
- Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations--a meta-analysis of randomized controlled studies.
- Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.
- A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.